The latest shared research on AsiaPac
Comparison of Hantaan and Seoul Viral Infections Among Patients with Hemorrhagic Fever with Renal Syndrome (HFRS) in Heilongjiang, China
Abstract from: Comparison of Hantaan and Seoul viral infections among patients with hemorrhagic fever with renal syndrome (HFRS) in Heilongjiang, China, Xin Zhang, Huan-Yong Chen, Li-Ying Zhu, Ling-Lan Zeng, Fei Wang, Qing-Gang Li, Feng-Juan Shao, Hong-Qi Jiang, Shi-Jie Liu, Ying-Jie Ma, You Zhu, Ying-Ji Ma, Scandinavian Journal of Infectious Diseases Aug 2011, Vol. 43, No. 8, Pages 632-641: 632-641. Background: Hemorrhagic fever with renal syndrome (HFRS) is a serious public health problem in China, and is primarily caused by either the Hantaan virus (HTNV) or Seoul virus (SEOV) strains. However, the causative hantavirus has only been definitively identified in a few HFRS ...
The Cost Effectiveness of Rapid-Acting Insulin Aspart Compared with Human Insulin in Type 2 Diabetes Patients: An Analysis From the Japanese Third-Party Payer Perspective
Abstract from: The cost effectiveness of rapid-acting insulin aspart compared with human insulin in type 2 diabetes patients: an analysis from the Japanese third-party payer perspective, R.F. Pollock, W.J. Valentine, T. Pilgaard, H. Nishimura, Journal of Medical Economics Feb 2011, Vol. 14, No. 1, Pages 36-46: 36-46. Objectives: The Nippon Ultra-Rapid Insulin and Diabetic Complication Evaluation Study (NICE Study) (NCT00575172) was a 5-year, open-label, randomised controlled trial which compared cardiovascular outcomes in Japanese type 2 diabetes patients intensively treated with regular human insulin or insulin aspart (NovoRapid; Novo Nordisk A/S, Bagsværd, Denmark), a rapid-acting insulin analogue. The aim of the present analysis ...
Asia Beat: Political Breakthrough Edges Indonesia Closer to Universal Care
Ian Haydock After more than six years of political stalling, Indonesia finally seems close to passing a bill for the reform of its social security system, including the provision of health insurance, in a move that could reshape the healthcare landscape in the country. Expectations that the discussions would be wrapped up before the current parliamentary recess proved optimistic, but hopes are now running high that the impasse has been broken and the proposed legislation will pass in the next few months. For the millions of people with no coverage who fall into the cracks in the current fragmented system, the ...
